Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) has a beta value of 1.47 and has seen 1,476,390 shares traded in the last trading session. The company, currently valued at $61.58 Million, closed the last trade at $1.11 per share which meant it gained $0.05 on the day or 4.72% during that session. The CTXR stock price is -77.48% off its 52-week high price of $1.97 and 63.96% above the 52-week low of $0.4. If we look at the company’s 10-day average daily trading volume, we find that it stood at 952.39 Million shares traded. The 3-month trading volume is 1.28 Million shares.

The consensus among analysts is that Citius Pharmaceuticals, Inc. (CTXR) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.16.

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) trade information

Sporting 4.72% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Oct 16 when the CTXR stock price touched $1.12 or saw a rise of 0.89%. Year-to-date, Citius Pharmaceuticals, Inc. shares have moved 8.82%, while the 5-day performance has seen it change 5.71%. Over the past 30 days, the shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) have changed 4.72%. Short interest in the company has seen 809.12 Million shares shorted with days to cover at 632.13.

Wall Street analysts have a consensus price target for the stock at $5.5, which means that the shares’ value could jump 395.5% from current levels. The projected low price target is $4 while the price target rests at a high of $7. In that case, then, we find that the current price level is +530.63% off the targeted high while a plunge would see the stock lose 260.36% from current levels.

Citius Pharmaceuticals, Inc. (CTXR) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -6.2% over the past 5 years. Earnings growth for 2020 is a modest +33.9%.